Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Vietnam Medi-Pharm Exp...Vietnam Medi-Pharm Expo
Not Confirmed
Not Confirmed
31 July-02 August, 2025
Not Confirmed
Not Confirmed
12-14 August, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Vietnam Medi-Pharm Exp...Vietnam Medi-Pharm Expo
Industry Trade Show
Not Confirmed
31 July-02 August, 2025
Industry Trade Show
Not Confirmed
12-14 August, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
18 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/medison-expands-global-leadership-team-with-chief-business-officer-and-chief-legal--compliance-officer-302485327.html
30 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/medison-pharma-and-alnylam-pharmaceuticals-announce-expansion-of-their-multi-regional-partnership-in-europe-and-israel-to-commercialize-rnai-therapeutics-in-additional-latam-and-apac-markets-including-australia-302131423.html
08 Jan 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/medison-pharma-announces--agreement-with-regeneron-pharmaceuticals-to-commercialize-libtayo-cemiplimab-in-multiple-countries-302028359.html
08 Jan 2024
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/regeneron-hands-certain-european-libtayo-rights-medison-pharma
13 Nov 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ipsen-and-medison-pharma-announce-health-canada-approval-of-bylvay-odevixibat-for-the-treatment-of-pruritus-due-to-progressive-familial-intrahepatic-cholestasis-pfic-301986009.html
29 Sep 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/medison-pharma-announces-public-formulary-listing-of-qinlock-ripretinib-in-canadian-provinces-ontario-and-quebec-for-advanced-gastrointestinal-stromal-tumor-gist-treatment-301942841.html
ABOUT THIS PAGE